RA
Radiopharm Theranostics Limited (RADX)
NASDAQ·Healthcare·Biotechnology
$0.90
—
Mkt Cap $6.36M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+566.7%
Consensus $6.00 vs current $0.90
NASDAQ·Healthcare·Biotechnology
$0.90
—
Mkt Cap $6.36M
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
+566.7%
Consensus $6.00 vs current $0.90